• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

5.650 -0.883 (-13.52%)
Official Closing Price Updated: 8:00 PM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,057
Open 6.570
Bid (Size) 5.510 (300)
Ask (Size) 5.700 (200)
Prev. Close 6.533
Today's Range 5.440 - 6.870
52wk Range 0.6149 - 40.31
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
July 21, 2026
Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million. Apimeds Pharmaceuticals... 
Via Benzinga
TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Bridging Gap Between Traditional Finance and Web3
July 17, 2026
Via Investor Brand Network
Topics Artificial Intelligence

Performance

YTD
-66.1%
-66.1%
1 Month
+534.8%
+534.8%
3 Month
+88.3%
+88.3%
6 Month
-74.1%
-74.1%
1 Year
-73.0%
-73.0%

More News

Read More
The Next Generation of Treasury Management: How MindWave Innovations Inc. (NYSE American: APUS) Is Building for Programmable Corporate Reserves
July 15, 2026
Via Investor Brand Network
Topics Bonds
MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Advancing Platform for Institutional Bitcoin Treasury Strategies
July 02, 2026
Via Investor Brand Network
Bridging Traditional Finance and Web3: MindWave Innovations Inc.’s (NYSE American: APUS) Vision for Corporate Digital Asset Treasuries
July 02, 2026
Via Investor Brand Network
Topics Economy
TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Integrates AI, Blockchain to Optimize Digital Asset Treasury Management
June 30, 2026
Via Investor Brand Network
Topics Artificial Intelligence Economy
From Ownership to Utility: How Digital Assets Are Becoming Productive Capital
June 26, 2026
Via CryptoCurrencyWire
From Ownership to Utility: How Digital Assets Are Becoming Productive Capital
June 26, 2026
Via Investor Brand Network
MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Offers Secure Gateway to Digital Assets
June 24, 2026
Via Investor Brand Network
MindWave Innovations Inc. (NYSE American: APUS) Is Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management
June 18, 2026
Via Investor Brand Network
Topics Artificial Intelligence Economy
TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Taps Growing Demand for Yield-Generating Solutions
June 11, 2026
Via Investor Brand Network
Traders are paying attention to the gapping stocks in Thursday's session. ↗
June 11, 2026
Via Chartmill
MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Bridge for Bitcoin Treasury Adoption
June 11, 2026
Via Investor Brand Network
Topics Economy
Bitcoin as a Corporate Treasury Asset: How MindWave Innovations Inc. (NYSE American: APUS) Is Redefining Institutional Yield Infrastructure
June 05, 2026
Via Investor Brand Network
Topics Artificial Intelligence Economy
The Infrastructure Gap Behind Corporate Bitcoin Adoption
June 01, 2026
Via Investor Brand Network
News headline image
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
May 05, 2026
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
April 16, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
April 15, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
March 25, 2026
Via CryptoCurrencyWire
Topics Artificial Intelligence Economy
MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
March 25, 2026
Via Investor Brand Network
Topics Artificial Intelligence Economy
News headline image
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
From Apimeds Pharmaceuticals US, Inc.
Via GlobeNewswire
News headline image
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
March 24, 2026
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
February 11, 2026
From Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc.
Via Business Wire
News headline image
Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
December 10, 2025
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
December 01, 2025
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire

Frequently Asked Questions

Is Apimeds Pharmaceuticals US, Inc. Common Stock publicly traded?
Yes, Apimeds Pharmaceuticals US, Inc. Common Stock is publicly traded.
What exchange does Apimeds Pharmaceuticals US, Inc. Common Stock trade on?
Apimeds Pharmaceuticals US, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock?
The ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock is APUS on the New York Stock Exchange
What is the current price of Apimeds Pharmaceuticals US, Inc. Common Stock?
The current price of Apimeds Pharmaceuticals US, Inc. Common Stock is 5.650
When was Apimeds Pharmaceuticals US, Inc. Common Stock last traded?
The last trade of Apimeds Pharmaceuticals US, Inc. Common Stock was at 07/24/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap